Literature DB >> 4722431

Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.

R G Aptekar, J P Atkinson, J L Decker, S M Wolff, E W Chu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4722431     DOI： 10.1002/art.1780160405

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Proceedings: Trial of azathioprine, cyclophosphamide, and gold in rheumatoid arthritis.

Authors:  J Woodland; R M Mason; J Harris; A S Dixon; H L Currey; A M Brownjohn; J Davies; B D Owen-Smith
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

3.  Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.

Authors:  J A Murray
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

Review 4.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

5.  Mesna side effects which imitate vasculitis.

Authors:  E Reinhold-Keller; J Mohr; E Christophers; K Nordmann; W L Gross
Journal:  Clin Investig       Date:  1992-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.